In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

COVID-19 vaccination in early pregnancy (≤20 weeks of gestation) is not associated with increased prevalence of major structural birth defects.

A preprint study posted late last week on the server medRxiv reveals that the current Moderna COVID-19 vaccine is 53% effective against COVID-19–related hospitalization and 39% protective against ...

MRNA technology is facing growing doubts among Republicans. This is a KFF Health News story. Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology ...

Vaccine skeptics have long-since leveraged the rapid roll out of mRNA vaccines to add fuel to heated arguments surrounding vaccine safety. As a result, a growing share of the public is wary of ...

A bill to make it a crime to administer mRNA vaccines in Iowa — like the Moderna and Pfizer COVID shots — has cleared initial review in the Iowa Senate. However, the bill’s sponsor plans to ...

Yet vaccines using the new technology of mRNA were developed by Moderna and Pfizer/BioNTech in a matter of months, and were already being put into arms by the first anniversary of the pandemic.

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes. Study participants were ...